Doxepin
Links shared publicly online about this topic
Somaxon Announces FDA Approval of Silenor (doxepin) for the Treatment of Insomnia
drugs.com — “Silenor (doxepin) is used to treat insomnia characterized by difficulty with sleep maintenance. Includes Silenor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 23, 2010 at 1:23 am By:
Somaxon Announces FDA Approval of Silenor (doxepin) for the Treatment of Insomnia - http://bit.ly/b7K3PK
Somaxon Announces FDA Approval Of Silenor(R) (doxepin) For The Treatment Of Insomnia
medicalnewstoday.com — “Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Silenor® (doxepin) for the treatme” View full resource at medicalnewstoday.com
Most Recently Shared on March 20, 2010 at 5:37 am By:
Somaxon Announces FDA Approval Of Silenor(R) (doxepin) For The Treatment Of Insomnia Somaxon Pharmaceuticals, Inc. (N.. http://bit.ly/9eRDbZ
Brain Posts: Low-dose Doxepin for Insomnia Treatment
brainposts.blogspot.com — “Commentary on research in clinical neuroscience” View full resource at brainposts.blogspot.com
Most Recently Shared on January 21, 2011 at 4:14 pm By:
William Yates, M.D. Doctor, Psychiatrist, Family Medicine Doctor, and Physician
An old drug (doxepin) gets a new look as a treatment for insomnia. New Brain Post. http://ht.ly/3HVwK
Structure of the human histamine H1 receptor complex with doxepin : Nature : Nature Publishing Group
nature.com — “Structure of the human histamine H1 receptor complex with doxepin : Nature : Nature Publishing Group” View full resource at nature.com
Most Recently Shared on August 6, 2011 at 8:16 pm By:
Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician
Molecular basis of human histamine H1 receptor antagonist specificity http://bit.ly/nRYPxL
Silenor® (doxepin) | For People with Insomnia who Have Difficulty Staying Asleep
silenor.com — “Silenor® (doxepin tablets) is a prescription treatment approved by the FDA. Get information and learn how Silenor may help you.” View full resource at silenor.com
Most Recently Shared on September 30, 2010 at 1:12 pm By:
Stephen Meyers, MD Doctor, Family Medicine Doctor, and Physician
Insomnia: "New" drug Silenor (Somaxon Pharm.) available. Savings card for $25 off 3 refills available online http://www.silenor.com #drugs
Positive Results Announced Of Phase II Clinical Trial Of Dolorac(R) Nasal Solution For Chronic Migraine
medicalnewstoday.com — “Winston Pharmaceuticals, Inc. (Winston), a specialty pharmaceutical company focused on developing and commercializing novel pain management therapies, announced the results of its Phase II study” View full resource at medicalnewstoday.com
Most Recently Shared on November 25, 2010 at 2:38 pm By:
Positive Results Announced Of Phase II Clinical Trial Of Dolorac(R) Nasal Solution For Chronic Migraine: Winston... http://mnt.to/f/3N96
Winston Pharmaceuticals, Inc. Announces Positive Results of Phase II Clinical Trial of Dolorac Nasal Solution - Drugs.com MedNews
drugs.com — “Nov 22, 2010 - Winston Pharmaceuticals, Inc. ( Winston ), a specialty pharmaceutical company focused on developing and commercializing novel pain management the” View full resource at drugs.com
Most Recently Shared on November 22, 2010 at 7:08 pm By:
Drugs and Devices OW OW Health
Winston Pharmaceuticals, Inc. Announces Positive Results of Phase II Clinical Trial of Dolorac Nasal Solut... http://bit.ly/9Nik0y #drug
Silenor available for sleep maintenance insomnia - MPR
empr.com — “Somaxon announced that Silenor (doxepin tablets) has been made available for the treatment of insomnia characterized by difficulty with sleep maintenance.” View full resource at empr.com
Most Recently Shared on September 7, 2010 at 5:16 pm By:
MPR News: Silenor available for sleep maintenance insomnia: Somaxon announced that Silenor (doxepin tablets) has b... http://bit.ly/doUFCL
Neurology News & Articles - MDLinx - Sleep Initiation and Maintenance Disorders on #MDlinx
mdlinx.com — “Neurology News & Articles - MDLinx - Sleep Initiation and Maintenance Disorders on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 15, 2010 at 12:04 pm By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
Efficacy and safety of doxepin 6 mg in a model of transient insomnia: Sleep Medicine http://bit.ly/c8LyVQ #neurology
Family Medicine News & Articles - MDLinx - Sleep Initiation and Maintenance Disorders on #MDlinx
mdlinx.com — “Family Medicine News & Articles - MDLinx - Sleep Initiation and Maintenance Disorders on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 15, 2010 at 10:38 am By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
Efficacy and safety of doxepin 6 mg in a model of transient insomnia: Sleep Medicine http://bit.ly/bcO12f #GM #mdlinx
SILENOR - New Product Releases - MPR
empr.com — “Treatment of insomnia characterized by difficulty with sleep maintenance.” View full resource at empr.com
Most Recently Shared on September 24, 2010 at 1:59 pm By:
MPR News: SILENOR: Doxepin (as HCl) 3mg, 6mg; tabs. http://bit.ly/9u7IuT
Phase 2 study of Dolorac nasal solution for the prophylaxis of chronic migraine (CM) - MPR
empr.com — “Winston Pharmaceuticals announced the results of its Phase 2 study of Dolorac (doxepin 0.4% nasal solution) for prophylaxis of chronic migraine (CM).” View full resource at empr.com
Most Recently Shared on November 23, 2010 at 7:17 pm By:
MPR News: Phase 2 study of Dolorac nasal solution for the prophylaxis of chronic migraine (CM): Winston Pharmace... http://bit.ly/i0n4g1
Elorac acquires world-wide rights to Cidoxepin
news-medical.net — “Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, is pleased to announce that it has acquired world-wide rights to the active agent Cidoxepin from Gideon Pharmaceuticals. Cidoxepin is the cis-isomer of the widely prescribed tricyclic compound doxepin.” View full resource at news-medical.net
Most Recently Shared on October 19, 2010 at 4:35 am By:
Elorac acquires world-wide rights to Cidoxepin: Elorac, Inc., a rapidly growing specialty pharmaceutical company f... http://bit.ly/anEckQ
Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa
news-medical.net — “Somaxon Pharmaceuticals, Inc. and Paladin Labs Inc. today announced that they have entered into an exclusive collaboration under which Paladin will commercialize Silenor® (doxepin) for the treatment of insomnia characterized by difficulty with sleep maintenance in Canada, South America and Africa.” View full resource at news-medical.net
Most Recently Shared on June 8, 2011 at 2:24 pm By:
Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa: Somaxon Pharmace... http://bit.ly/iseLpT
Somaxon announces nonreceipt of Paragraph IV certification for generic Silenor ANDA
news-medical.net — “Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the website of the U.S. Food and Drug Administration (FDA) indicates that an Abbreviated New Drug Application (ANDA) for a generic version of Silenor® (doxepin) 3 mg and 6 ” View full resource at news-medical.net
Most Recently Shared on October 19, 2010 at 4:35 am By:
Somaxon announces nonreceipt of Paragraph IV certification for generic Silenor ANDA: Somaxon Pharmaceuticals, Inc.... http://bit.ly/bMu7t0
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
medical_tweets
-
William Yates, M.D.
Clinical Neuroscientist. Research Psychiatrist, Laureate Institute of Brain Research (laureateinstitute.org) Professor of Research, University of Oklahoma.
Advertisement
